The role of PSMC4 in non-small cell lung cancer: implications for prognosis, diagnosis, and immune microenvironment modulation
These results highlight the potential of PSMC4 as a diagnostic and prognostic marker in NSCLC and elucidate its integral role within the tumor immune microenvironment. Consequently, targeting PSMC4 emerges as a viable therapeutic approach for NSCLC.
Authors
- Yuanjun Li
- Jian Lei (ORCID: https://orcid.org/0000-0002-7617-2170)
- Yunfei Xu (ORCID: https://orcid.org/0000-0002-0580-7116)
- Lili Zhu (ORCID: https://orcid.org/0009-0003-4119-5270)
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.3389/fonc.2025.1503466
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00